# Hyperthermia With Chemoradiotherapy in Rectal Cancer

> **NCT06831981** · NA · RECRUITING · sponsor: **University Hospital Tuebingen** · enrollment: 264 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **OTHER:** Hyperthermia
- **RADIATION:** Radiotherapy
- **DRUG:** Chemotherapy with 5-fluorouracil
- **DRUG:** Consolidation chemotherapy with FOLFOX

## Key facts

- **NCT ID:** NCT06831981
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-11
- **Primary completion:** 2036-06-01
- **Final completion:** 2037-03-01
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2025-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06831981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06831981, "Hyperthermia With Chemoradiotherapy in Rectal Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06831981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*